Search Results

(SG-1812-28-H) update Oscor Inc. Issues Recall of TB Temporary Bipolar Pacing Lead (Unshrouded 2 mm Pins Models) Medical Report

(SG-1811-27-H) Oscor Inc. Issues Recall of TB Temporary Bipolar Pacing Lead (Unshrouded 2 mm Pins Models) Medical Report

SFDA: “ E129 & E110 Colours are allowed to be used, with a statement advising that they may affect Children” Warnings

A Phase 3, randomized, double-blind, placebo-controlled, parallel-group, 3-arm, multinational, multicenter study to evaluate the efficacy and safety of amlitelimab by subcutaneous injection in participants aged 18 years and older with moderate-to-severe atopic dermatitis (AD) who are on background topical corticosteroids and have had an inadequate response to prior biologic therapy or oral Janus Kinase (JAK) inhibitor treatment Drug Clinical Trial

(SG-2101-293-H) An elevated imprecision at low concentration range with current reagent lots v2.0 Medical Report

Safety Warning : The Risk of death associated with intravenous administration of undiluted Ranitidine 50 mg/2ml Circulars

An Open Label, Randomised Phase III Trial of BIBW 2992 and Vinorelbine Versus Trastuzumab and Vinorelbine in Patients With Metastatic HER2-overexpressing Breast Cancer Failing One Prior Trastuzumab Treatment Drug Clinical Trial

A Randomized, Open-label Trial of Paritaprevir Plus Ritonavir Plus Ombitasvir in the Treatment of HCV Genotype 4 Infected Patients with Stage 4-5 Chronic Kidney Disease Drug Clinical Trial

An Open Label, Randomised Phase III Trial of BIBW 2992 and Vinorelbine Versus Trastuzumab and Vinorelbine in Patients With Metastatic HER2-overexpressing Breast Cancer Failing One Prior Trastuzumab Treatment Drug Clinical Trial

S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer Drug Clinical Trial

Displaying 1571 - 1580 of 2239